| News News Main Page  Email A Friend
April 17, 2025
California Division of Workers' Compensation Issues Notice of Second 15-Day Public Comment Period for Utilization Review and Related Regulations April 15, 2025
California Division of Workers' Compensation Posts Reminder for the Return-To-Work Supplemental Program (RTWSP) Application Requirements April 8, 2025
California's Department of Industrial Relations, Division of Workers' Compensation Releases Independent Medical Review (IMR) Report for 2024 April 8, 2025
California Division of Workers' Compensation Posts Adjustments to Official Medical Fee Schedule for Pathology and Clinical Laboratory
| | California Division of Workers' Compensation Pharmacy and Therapeutics Committee Meeting Scheduled for October 16, 2024
By Lonce Lamonte, adjustercom editor using DWC Newsline's News Release Dated October 3rd 2024 - October 3, 2024The Division of Workers’ Compensation (DWC) Pharmacy and Therapeutics (P&T) Committee meeting is scheduled for Wednesday, October 16, 2024, from 12:30 p.m. to 2:30 p.m. P&T Committee members will attend the meeting remotely on a virtual internet platform that may also be accessed by the public. In addition, DWC will host a physical location for members of the public who may wish to access the virtual meeting in person at the Oakland state building.
The meeting is open to the public and can be accessed remotely or in-person.
• The video conference meeting can be joined at the P&T Meeting Link
or via telephone at 1 (619) 407-9860, phone conference ID: 222 309 788 766; Passcode: xpFFPw
• The meeting can be joined in person at the Elihu Harris State Building, 1515 Clay Street, Room #11 (2nd Floor), Oakland, CA 94612
The Pharmacy and Therapeutics Committee is established pursuant to Labor Code section 5307.29 as an advisory body to consult with the DWC Administrative Director on updates to the Medical Treatment Utilization Schedule (MTUS) drug formulary. Government Code section 11123.5 authorizes public meetings of advisory bodies to be conducted virtually through December 31, 2025, and requires the agency to provide a physical meeting location where members of the public may physically attend, observe, hear and participate in the video/audio online meeting.
The meeting agenda and related materials are posted on the DWC P&T Committee webpage. DWC welcomes comment from the public on the formulary drug list. All correspondence should be directed to Formulary@dir.ca.gov.
# # #
lonce@adjustercom.com, Lonce Lamonte, journalist, editor, adjustercom; editing the DWC Newsline news release from October 3rd 2024
|
.gif)